Fixed Dose Combination Versus Free Combination of Tiotropium and Olodaterol in COPD

NCT02683109 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

221

Enrollment

INDUSTRY

Sponsor class

Conditions

Pulmonary Disease, Chronic Obstructive

Interventions

DRUG: FDC of tiotropium + olodaterol
DRUG: Placebo
DRUG: Tiotropium
DRUG: Olodaterol

Sponsor

Boehringer Ingelheim